• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于流行病学研究的非霍奇金淋巴瘤的病理分类

Pathological classification of non-Hodgkin's lymphoma for epidemiological studies.

作者信息

Weisenburger D D

机构信息

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198-3135.

出版信息

Cancer Res. 1992 Oct 1;52(19 Suppl):5456s-5462s; discussion 5462s-5464s.

PMID:1394154
Abstract

Non-Hodgkin's lymphoma (NHL) consists of a heterogeneous group of disorders which have been difficult to study by epidemiological means in the past. However, recent advances in knowledge of the biology of NHL and improvements in its classification will greatly improve the quality of epidemiological studies in the future. Use of the Working Formulation and the current International Classification of Diseases for Oncology, along with paraffin immunohistochemistry, allow the delineation of NHL subgroups with possible etiological significance based on the biology of the disease. The collaboration of epidemiologists with expert pathologists in the design, performance, and evaluation of epidemiological studies of NHL is essential for such studies to be meaningful.

摘要

非霍奇金淋巴瘤(NHL)由一组异质性疾病组成,过去通过流行病学方法很难对其进行研究。然而,近期NHL生物学知识的进展及其分类的改进将极大地提高未来流行病学研究的质量。使用工作分类法和当前的国际肿瘤疾病分类法,结合石蜡免疫组织化学,能够根据疾病生物学特性界定出可能具有病因学意义的NHL亚组。在NHL流行病学研究的设计、实施和评估过程中,流行病学家与专业病理学家的合作对于此类研究具有意义至关重要。

相似文献

1
Pathological classification of non-Hodgkin's lymphoma for epidemiological studies.用于流行病学研究的非霍奇金淋巴瘤的病理分类
Cancer Res. 1992 Oct 1;52(19 Suppl):5456s-5462s; discussion 5462s-5464s.
2
[Non-Hodgkin's lymphoma: morphologic, immunologic and cytogenetic classification].[非霍奇金淋巴瘤:形态学、免疫学及细胞遗传学分类]
Srp Arh Celok Lek. 1996 Sep-Oct;124(9-10):276-82.
3
The emerging epidemic of non-Hodgkin's lymphoma: current knowledge regarding etiological factors. Time trends and pathological classification: a summary.非霍奇金淋巴瘤的新发病趋势:关于病因因素的当前认知。时间趋势及病理分类:综述
Cancer Res. 1992 Oct 1;52(19 Suppl):5570s.
4
[Pathological classification of malignant lymphoma].[恶性淋巴瘤的病理分类]
Gan No Rinsho. 1988 Apr;34(5):529-39.
5
[Clinical staging classification of non-Hodgkin's lymphoma].[非霍奇金淋巴瘤的临床分期分类]
Nihon Rinsho. 2000 Mar;58(3):598-601.
6
REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma.韩国恶性淋巴瘤的REAL分类:近期确认实体的发病率及临床病理特征变化。韩国病理学家协会血液淋巴网状组织研究组。修订的欧美淋巴瘤分类。
Cancer. 1998 Aug 15;83(4):806-12.
7
Non-Hodgkin's lymphoma. Understanding the disease.非霍奇金淋巴瘤。了解这种疾病。
Cancer Nurs. 1990 Feb;13(1):56-61.
8
[Histopathology of malignant lymphomas].[恶性淋巴瘤的组织病理学]
Rinsho Byori. 1990 Apr;38(4):386-9.
9
New REAL clinical entities.新的REAL临床实体。
Cancer J Sci Am. 1998 Jul;4 Suppl 2:S5-12.
10
Use of the working formulation for non-Hodgkin's lymphoma in epidemiologic studies: agreement between reported diagnoses and a panel of experienced pathologists.
J Natl Cancer Inst. 1987 Jun;78(6):1137-44.

引用本文的文献

1
Exposure to glyphosate-based herbicides and risk for non-Hodgkin lymphoma: A meta-analysis and supporting evidence.接触草甘膦类除草剂与非霍奇金淋巴瘤风险:荟萃分析及支持证据。
Mutat Res Rev Mutat Res. 2019 Jul-Sep;781:186-206. doi: 10.1016/j.mrrev.2019.02.001. Epub 2019 Feb 10.
2
Unusual presentation of non-Hodgkin's lymphoma: Case report and review of literature.非霍奇金淋巴瘤的罕见表现:病例报告及文献复习
J Oral Maxillofac Pathol. 2016 Sep-Dec;20(3):510-517. doi: 10.4103/0973-029X.190956.
3
Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA).
国际癌症研究机构(IARC)与欧洲食品安全局(EFSA)对草甘膦致癌性评估的差异。
J Epidemiol Community Health. 2016 Aug;70(8):741-5. doi: 10.1136/jech-2015-207005. Epub 2016 Mar 3.
4
A Systematic Review of Carcinogenic Outcomes and Potential Mechanisms from Exposure to 2,4-D and MCPA in the Environment.环境中接触2,4-滴和灭草灵的致癌结果及潜在机制的系统评价
J Toxicol. 2013;2013:371610. doi: 10.1155/2013/371610. Epub 2013 Feb 26.
5
Are there any significant variations in the clinical or histological presentation of lymphoid pathologies over the course of time in Spain?在西班牙,淋巴组织病理学的临床表现或组织学表现是否随着时间的推移而存在显著差异?
Clin Transl Oncol. 2012 May;14(5):386-90. doi: 10.1007/s12094-012-0813-3.
6
Analysis of matched geographical areas to study potential links between environmental exposure to oil refineries and non-Hodgkin lymphoma mortality in Spain.分析匹配的地理区域,以研究西班牙炼油厂环境暴露与非霍奇金淋巴瘤死亡率之间的潜在联系。
Int J Health Geogr. 2012 Feb 6;11:4. doi: 10.1186/1476-072X-11-4.
7
Non-Hodgkin lymphoma (NHL) subtypes defined by common translocations: utility of fluorescence in situ hybridization (FISH) in a case-control study.由常见易位定义的非霍奇金淋巴瘤(NHL)亚型:荧光原位杂交(FISH)在一项病例对照研究中的应用
Leuk Res. 2010 Feb;34(2):190-5. doi: 10.1016/j.leukres.2009.05.007. Epub 2009 Jun 7.
8
The utility of t(14;18) in understanding risk factors for non-Hodgkin lymphoma.t(14;18)在理解非霍奇金淋巴瘤风险因素中的作用。
J Natl Cancer Inst Monogr. 2008(39):69-73. doi: 10.1093/jncimonographs/lgn018.
9
Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph).国际淋巴瘤流行病学联盟(InterLymph)病理学工作组提出的用于流行病学研究的淋巴样肿瘤分类。
Blood. 2007 Jul 15;110(2):695-708. doi: 10.1182/blood-2006-11-051672. Epub 2007 Mar 27.
10
Agricultural pesticide use and risk of t(14;18)-defined subtypes of non-Hodgkin lymphoma.农业杀虫剂使用与t(14;18)定义的非霍奇金淋巴瘤亚型风险
Blood. 2006 Aug 15;108(4):1363-9. doi: 10.1182/blood-2005-12-008755. Epub 2006 Apr 18.